Monitor for any future conversion to Schedule 13D, which would signal activist intent. The stake is passive for now with no change in control implications.
How the stock moved after the report
⚠ Clustered NEUTRAL VIEWSTOCK BELOW ENTRY AT T+5- T+0 · Nov 6 $1.30entry
- T+1 · 8d ago +15.38%α +13.02% · $1.50
- T+5 · 4d ago −1.54%α −4.13% · $1.28
- T+6 · todayOpen
- T+20 · in 20d Pending
- T+60 · in 3mo Pending
Price Chart
REPLAYWatch the reaction play outHow similar events traded
Executive Summary
T. Rowe Price Investment Management filed an amended Schedule 13G for Cabaletta Bio, reporting beneficial ownership of 17,250,098 shares (8.0% of common stock) as of September 30, 2026. This is a routine passive stake update by a large asset manager; no prior T. Rowe Price 13G for CABA is in the provided context for comparison, so the direction of change is unknown. The filing has no material directional impact.
Key Financial Metrics
Key Facts
- T. Rowe Price Investment Management reported beneficial ownership of 17,250,098 shares of Cabaletta Bio common stock as of September 30, 2026
- The stake represents 8.0% of the outstanding common stock
- The filing is an amendment to Schedule 13G, indicating passive investment intent
- No prior T. Rowe Price 13G for CABA is in the provided context, so the direction of change from the previous filing is unknown
Financial Impact
8.0% passive stake valued at approximately $19.3M based on $241M market cap
Risk Factors
- No prior filing for comparison, so direction of change is unknown
- Passive filing; no indication of activist intent
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 3 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| SC 13G/A Filing (Primary) | 0001897612-26-000701 |
| Document: 0001897612-26-000701-index.html | 0001897612-26-000701 |
| Document: 0001897612-26-000701.txt | 0001897612-26-000701 |
Track record
29 reports on CABA
4 of 9 bullish or bearish reports moved the stock their way by T+5. Best: +31.59% at T+60 after the May 4, 2026 report. 5 of 9 went positive at some point.
Filters
- Nov 16, 2026today SC 13G/A Neutral 2/10 Entry $1.15 Now $1.11 −3.09% settles Nov 23
- Nov 16, 2026today SC 13G/A Neutral 3/10 Entry $1.32 Now $1.11 −15.91% settles Nov 23
- Nov 12, 20264d ago SC 13G/A Neutral 2/10 Entry $1.33 Now $1.11 −16.54% settles Nov 19
- Nov 9, 20267d ago Institutional Cluster Neutral 3/10 Entry $1.45 Now $1.11 −23.45% settles Nov 17
- Nov 9, 20267d ago 8-K Bullish 6/10 Entry $1.50 to $1.11 Now $1.11 −26.00% ▼ −26.00% −24.31% vs SPY
- Nov 8, 20268d ago Press Release Bullish 6/10 Entry $1.50 to $1.11 Now $1.11 −26.00% ▼ −26.00% −24.31% vs SPY
- Nov 6, 202610d ago SC 13G/A Neutral 2/10 Entry $1.30 to $1.28 Now $1.11 −14.62% ▼ −1.54% −4.13% vs SPY
- Nov 6, 202610d ago SC 13G/A Neutral 2/10 Viewing Entry $1.30 to $1.28 Now $1.11 −14.62% ▼ −1.54% −4.13% vs SPY
- Nov 5, 202611d ago 8-K Neutral 4/10 Entry $1.28 to $1.33 Now $1.11 −13.28% ▲ +3.91% +0.62% vs SPY
- Nov 5, 202611d ago Press Release Neutral 4/10 No price data
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers